Literature DB >> 16877188

Successful palliation with octreotide of a neuroendocrine syndrome from malignant melanoma.

Alexander W Jahng1, Solomon S Liao.   

Abstract

We present a unique case of a neuroendocrine syndrome in a patient with Stage IV vaginal melanoma metastatic to the liver that was successfully palliated with octreotide. Similar to the carcinoid syndrome, the patient exhibited chronic diaphoresis, intermittent low-grade fevers, dizziness, nausea with vomiting, and hot flashes. The symptoms on admission of acute hypotension, acute exacerbation of abdominal pains, and intractable nausea with vomiting suggested a neuroendocrine crisis secondary to massive degranulation and hormone release. Consistent with our hypothesis, her plasma chromogranin A was found to be elevated. Octreotide was used successfully to palliate her symptoms. When the octreotide was stopped, all her symptoms returned. As the use of octreotide is gaining application in palliative care, this case highlights the effectiveness of its use in a select group of patients whose symptoms would be otherwise difficult to manage.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16877188     DOI: 10.1016/j.jpainsymman.2006.02.014

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  2 in total

1.  Base of tongue metastasis of cutaneous malignant melanoma with rhabdoid and neuroendocrine features: Report of a rare case and review of the literature.

Authors:  Konstantinos Tzanavaris; Efstathios Pettas; Grigorios Thermos; Maria Georgaki; Evangelia Piperi; Nikolaos G Nikitakis
Journal:  Head Neck Pathol       Date:  2022-05-06

2.  The Application of ATR Kinase Inhibitor AZD6738 in Combination with Radiotherapy for the Treatment of Melanoma.

Authors:  Maryam Talebpoor; Ali Neshasteh-Riz; Fereshteh Koosha; Samira Eynali
Journal:  J Biomed Phys Eng       Date:  2022-06-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.